KM
KMC Speciality Hospitals (India) Ltd (KMCSHIL)
₹203.78
Mkt cap
₹3,324 Cr
P/E ratio
54.40
P/B
13.68
Div yield
0.00%
ROE
24.90%
ROCE
26.20%
EPS (TTM)
₹3.75
Book value
₹15
52W range
128–210
Sector
Healthcare
Price history
Previous close
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
NSE KMCSHILBSE 524520
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−3.08% from high₹204
₹128+58.61% from low₹210
Current
₹203.78
Prev close
₹201.64
Day
+1.06%
Price performance
1D
+1.05%
1W
+21.36%
1M
+34.47%
3M
+48.79%
6M
—
1Y
—
YTD
+42.37%
Financials
Revenue, profit & margin
P/E ratio
54.4×
KMCSHIL is 0% above the sector median of 54.4×
KMCSHIL54.4×
Sector median54.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 49 | 45 | 53 | 56 | 61 | 61 | 67 | 75 | 82 | 82 | 92 | 93 | |
| YoY Sales growth | +7% | +23% | +9% | +30% | +33% | +25% | +36% | +25% | +33% | +34% | +35% | +38% | +24% | |
| Expenses | 31 | 35 | 33 | 40 | 44 | 45 | 46 | 50 | 54 | 57 | 56 | 63 | 65 | |
| Operating Profit | 11 | 14 | 12 | 13 | 13 | 16 | 15 | 16 | 21 | 25 | 26 | 28 | 28 | |
| OPM % | 26% | 29% | 26% | 24% | 22% | 26% | 25% | 25% | 28% | 30% | 31% | 31% | 30% | |
| Other Income | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | |
| Interest | 0 | 0 | 0 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
| Depreciation | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | |
| Profit before tax | 9 | 12 | 9 | 7 | 5 | 10 | 9 | 10 | 15 | 18 | 20 | 22 | 22 | |
| Tax % | 26% | 24% | 25% | 26% | 27% | 25% | 49% | 25% | 26% | 26% | 26% | 26% | 25% | |
| Net Profit | 7 | 9 | 7 | 6 | 4 | 8 | 5 | 8 | 11 | 14 | 15 | 17 | 16 | |
| EPS in Rs | 0.42 | 0.58 | 0.43 | 0.34 | 0.24 | 0.46 | 0.28 | 0.46 | 0.66 | 0.84 | 0.90 | 1.02 | 0.99 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202675.00%Promoter
Promoters75.00%
FIIs0.03%
Public24.98%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹9,200.00 | 58.43 | 1,32,282 | 0.22% | 660 | +30.04% | 7,615 | +23.04% | 17.45% |
| Max Healthcare | ₹1,081.00 | 74.08 | 1,05,217 | 0.19% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Manipal Health | ₹702.20 | 98.49 | 92,366 | 0.00% | 285 | +10.29% | 3,399 | +37.32% | 12.10% |
| Aster DM Quality | ₹779.30 | 129.58 | 67,929 | 0.38% | 322 | +148.12% | 2,829 | +136.32% | 11.57% |
| Fortis Health. | ₹825.00 | 58.05 | 62,284 | 0.12% | 320 | +2.01% | 2,735 | +17.30% | 13.45% |
| Global Health | ₹1,480.20 | 61.47 | 39,799 | 0.03% | 219 | +51.38% | 1,469 | +33.64% | 17.37% |
| Narayana Hrudaya | ₹1,943.70 | 43.90 | 39,722 | 0.23% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| KMC Speciality | ₹203.78 | 54.35 | 3,324 | 0.00% | 16 | +49.63% | 93 | +24.09% | 26.24% |
| Median: 31 Co. | ₹492.10 | 54.35 | 7,200 | 0.00% | 40 | +22.67% | 431 | +22.77% | 14.62% |
Filings
Annual reports15
Concall transcripts11
Credit ratings6
Announcements5
Standalone Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2026 13 NovBoard Meeting Outcome for Outcome Of Board Meeting 13 Nov - Board approved standalone unaudited results for quarter and half-year ended September 30, 2026.Board Meeting Intimation for The Board Meeting Scheduled To Be Held On November 13 2026 6 Nov - Board meeting on 13 Nov 2026 to approve Q2 and half-year FY2027 unaudited results.Announcement under Regulation 30 (LODR)-Newspaper Publication 22 Oct - Newspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company.Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 14 Oct - Holding company rectified disclosure discrepancies for transactions dated 04/08/2026 and 04/09/2026.





